Research Papers:

Docking of CDK1 with antibiotic drugs revealed novel therapeutic value in breast ductal cancer in situ

Zhong-Hai Ding, Jia Qi, An-Quan Shang, Yu-Jie Zhang, Jun Wei, Li-Qing Hu, Wei-Wei Wang _ and Man Yang

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:61998-62010. https://doi.org/10.18632/oncotarget.18779

Metrics: PDF 2003 views  |   HTML 3210 views  |   ?  


Zhong-Hai Ding1,*, Jia Qi2,*, An-Quan Shang3,4,*, Yu-Jie Zhang5,**, Jun Wei5,**, Li-Qing Hu6, Wei-Wei Wang7 and Man Yang8

1Department of Senior Cadres’ Healthcare, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, Jiangsu, China

2Department of Dermatology, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi 214002, Jiangsu, China

3Department of Laboratory Medicine, Tongji Hospital of Tongji University, Shanghai 200092, Shanghai, China

4The Sixth People’s Hospital of Yancheng City, Yancheng 224005, Jiangsu, China

5Clinical Medicine School, Ningxia Medical University, Yinchuan 750004, Ningxia, China

6Department of Laboratory Medicine, The first Hospital of Ningbo City, Ningbo 315010, Zhejiang, China

7Department of Pathology, The First People’s Hospital of Yancheng City and The Sixth People’s Hospital of Yancheng City, Yancheng 224001, Jiangsu, China

8Department of Laboratory Medicine, TCM Hospital of Yancheng City Affiliated to Nanjing University of Chinese Medicine, Yancheng 224001, Jiangsu, China

*Zhong-Hai Ding, Jia Qi and An-Quan Shang are the first authors

**Yu-Jie Zhang and Jun Wei are the second authors

Correspondence to:

Wei-Wei Wang, email: [email protected]

Li-Qing Hu, email: [email protected]

Man Yang, email: [email protected]

Keywords: ductal cancer in situ, GEO, molecular signature, microarray, protein docking

Received: March 12, 2017    Accepted: May 07, 2017    Published: June 28, 2017


The aim of our research is to identify potential genes associated with Ductal carcinoma in situ (DCIS) through microarrays. The microarray dataset GS54665 were downloaded from the GEO(Gene Expression Omnibus) database. Dysregulated genes were screened and their associations with DCIS was analyzed by comprehensive bioinformatics tools. A total of 649 differential expression genes were identified between normal and DCIS samples, including 224 up-regulated genes and 425 down-regulated genes. Biological process annotation and pathway enrichment analysis identified several DCIS-related signaling pathways. Finally, PPI network was constructed with String website in order to get the hub codes involved in Ductal carcinoma in situ. We thus concluded that Five genes: CDK1, CCNB2, MAD2L1, PPARG, ACACB were finally identified to participate in the regulation and serve as potential diagnosis signatures in in Ductal carcinoma in situ. Finally, complmentarity between CDK1 and three drugs, Aminophenazone, Pomalidomide and the Rosoxacin, implies novel pharmacological value of those drugs in breast cancer.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18779